Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 8, 2026
Reporting period
Not applicable
Filed with the SEC
May 12, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001239126-26-000002
Filed / recorded
May 12, 2026, 9:00 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
AbbVie Inc.
Issuer CIK
1551152
Ticker
ABBV
Reporting person
Thomas C Freyman
Relationship
Director
Security
Common Stock, $0.01 par value
Table
Non-derivative (Table I)
Transaction date
May 8, 2026
Transaction code
A
Shares / units
1,118
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
127,869
Ownership form
Direct
Amendment
No
Footnotes from the filing
These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).